Recent significant positive changes in fundamentals have benefitted GSK plc (NYSE: GSK): the consensus estimate for December, 2024 increased significantly, significant quarterly sales acceleration occurred, and the consensus estimate for December, 2025 increased significantly.
Important positive changes in GSK plc (NYSE: GSK) investment behavior have recently occurred: its shorter term price trend turned up.
In light of these very positive signals we are reviewing our current Overall Rating of C. We would view the shares with optimism pending completion of this review in the next several days.
Current PriceTarget Research Rating
GSK’s future returns on capital are forecasted to be above the cost of capital. Accordingly, the company is expected to continue to be a major Value Builder.
GSK plc has a current Value Trend Rating of C (Neutral). The Value Trend Rating reflects consistent signals from PTR’s two proprietary measures of a stock’s attractiveness. GSK plc has a neutral Appreciation Score of 44 and a slightly positive Power Rating of 64, producing the Neutral Value Trend Rating.
Recent Price Action
GSK plc (NYSE: GSK) stock closed at $40.76 on 6/20/24 after a slight decline of -0.5%. However, this decline was accompanied by below average trading volume at 70% of normal. The stock has declined -0.7% during the last week but has been strong relative to the market over the last nine months.
Be the first to comment